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Genome-scale metabolic model of
the rat liver predicts effects of diet
restriction
Priyanka Baloni 1, Vineet Sangar1, James T. Yurkovich 1, Max Robinson 1, Scott Taylor2,
Christine M. Karbowski2, Hisham K. Hamadeh2,3, Yudong D. He2 & Nathan D. Price 1
Mapping network analysis in cells and tissues can provide insights into metabolic adaptations to
changes in external environment, pathological conditions, and nutrient deprivation. Here, we
reconstructed a genome-scale metabolic network of the rat liver that will allow for exploration of
systems-level physiology. The resulting in silico model (iRatLiver) contains 1,882 reactions, 1,448
metabolites, and 994 metabolic genes. We then used this model to characterize the response of the
liver’s energy metabolism to a controlled perturbation in diet. Transcriptomics data were collected from
the livers of Sprague Dawley rats at 4 or 14 days of being subjected to 15%, 30%, or 60% diet restriction.
These data were integrated with the iRatLiver model to generate condition-specific metabolic models,
allowing us to explore network differences under each condition. We observed different pathway usage
between early and late time points. Network analysis identified several highly connected “hub” genes
(Pklr, Hadha, Tkt, Pgm1, Tpi1, and Eno3) that showed differing trends between early and late time
points. Taken together, our results suggest that the liver’s response varied with short- and long-term
diet restriction. More broadly, we anticipate that the iRatLiver model can be exploited further to study
metabolic changes in the liver under other conditions such as drug treatment, infection, and disease.
Metabolic adaptation is critical for the ability of cells to maintain homeostasis following a physiological change.
One of the more important organs for regulating homeostasis is the liver, which plays a primary role in detoxification, protein synthesis, and nutrient regulation1,2. Homeostatic regulation in hepatocytes involves many metabolic processes spanning interconnected pathways, requiring a systems approach to provide mechanistic insight.
GEnome-scale metabolic Models (GEMs) provide one such systems biology framework for the quantitative
interrogation of metabolic capabilities across diverse conditions3. GEMs detail the connectivity of the metabolic
network through reaction stoichiometries, allowing for systems-level computation of reaction fluxes in response
to genetic or environmental perturbations4,5.
The scope of GEMs has been iteratively expanded to include additional pathways and physiological information, including various -omics data6–8. Notably, the integration of transcriptomics data has allowed for the
construction of condition-specific models9–12. The global human metabolic network reconstruction13–15 paved the
way for the use of GEMs to explore clinical applications and resulted in many cell- and tissue-specific GEMs16–18.
Several of these tissue-specific models have been used to study human physiology19–22 and pharmacological targets23–25. The hepatocyte has been the focus of several cell-specific modeling efforts. In 2010, two GEMs of the
human hepatocyte were published simultaneously26,27 to understand diverse physiological liver functions; one of
these models26 was later used to simulate metabolic phenotypes resulting from inborn errors of metabolism28.
A later GEM, iHepatocytes22,23, was used to predict serine deficiency in patients with non-alcoholic fatty liver
disease and to identify genes that are potential therapeutic targets for treatment of non-alcoholic steatohepatitis29.
While these cell-specific models have been used to understand pathophysiology in humans, the limitations
associated with perturbation experiments in humans have limited their utility in translation research. Thus,
organisms like Sprague Dawley rats (Rattus norvegicus) – small in size, easy to handle, high rate of reproduction,
and similar physiology to humans – have been used as a primary model organism to study toxicology30 and to
model aspects of human physiology30. Studying these diverse metabolic processes of the liver provides important
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Gene symbol

Enzyme

Enzyme name

Reaction formula

Pathway

Ref.

Glycine, serine and
threonine metabolism

41

Tdh

1.1.1.103

L-threonine 3-dehydrogenase

L-threonine + NAD+ = L-2-amino-3oxobutanoate + NADH + H+

Gulo

1.1.3.8

L-gulonolactone oxidase

L-gulono-1,4-lactone + O2 = L-ascorbate + H2O2

Ascorbate and aldarate
metabolism

43

Cmah

1.14.18.2

CMP-N-acetylneuraminate monooxygenase

CMP-N-acetylneuraminate + 2 ferrocytochrome
b5 + O2 + 2 H+ = CMP-N-glycoloylneuraminate + 2
ferricytochrome b5 + H2O

Amino sugar and
nucleotide sugar
metabolism

79

Uox

1.7.3.3

uric acid oxidase

urate + O2 + H2O = 5-hydroxyisourate + H2O2

Purine metabolism

45

80

Ggta1

2.4.1.87

N-acetyllactosaminide 3-alpha-galactosyltransferase

UDP-alpha-D-galactose + beta-D-galactosyl-(1->4)Glycosphingolipid
beta-N-acetyl-D-glucosaminyl-R = UDP + alpha-Dbiosynthesis - lacto
galactosyl-(1->3)-beta-D-galactosyl-(1->4)-beta-N-acetylglucosaminyl-R (where R can be OH, an oligosaccharide and neolacto series
or a glycoconjugate)

Art2b

3.2.2.5

NAD glycohydrolase

NAD+ + H2O = ADP-D-ribose + nicotinamide

Nicotinate and
nicotinamide
metabolism

81,82

RGD1309350

3.5.2.17

hydroxyisourate hydrolase

5-hydroxyisourate + H2O = 5-hydroxy-2-oxo-4-ureido-2,5dihydro-1H-imidazole-5-carboxylate

Purine metabolism

42

LOC688286

4.1.2.48

low-specificity L-threonine aldolase

L-threonine = glycine + acetaldehyde

Glycine, serine and
threonine metabolism

83

Table 1. Enzymes present in the rat liver but not in the human liver.

insights into the physiological response to pharmacological interventions31. One of the well-studied physiological
responses in the liver is due to a change in nutritional status, such as over-fed or starvation conditions32–34. During
a well-fed state, the liver stores excess glucose as glycogen, which is then converted back to glucose during glucose
deprivation. Understanding the metabolic regulatory responses to such perturbations in various physiological
models represents an important open area of research.
Here, we present the in silico investigation of the metabolic effects of different diet-restriction patterns as
interpreted through our reconstruction of a liver-specific GEM of the rat (iRatLiver). We generated genome-wide
transcriptomics data of the rat liver to assess the response to different feeding patterns. These data were then
integrated with iRatLiver to generate condition-specific models that were used to simulate changes in metabolic
pathway usage as a result of the dietary changes. More broadly, we anticipate that this model can be a useful
resource for toxicological and biomedical research, with its comparability back to the human reconstructions.

Results

Constructing the iRatLiver GEM. The first major step of this project was to reconstruct the metabolic
network of the rat liver35. Because we are ultimately interested in studying human physiology, we used an existing
GEM of the human liver16 as a starting point for the homology-based reconstruction of rat liver metabolism; see
Methods for details regarding the reconstruction process. The resulting model, iRatLiver, comprises 1882 reactions, 1448 metabolites, 994 genes, 7 compartments (cytoplasm, lysosome, mitochondria, nucleus, endoplasmic
reticulum, peroxisome, and extracellular space), and 82 metabolic subsystems (Supplementary Fig. 1); these subsystems were assigned according to the BiGG Models database36. We validated the iRatLiver model by comparing the predicted doubling time with literature values; the predicted doubling time of 16.3 hours was consistent
with the reported doubling time of 16.9 hours of rat hepatocytes in cell culture37. Further, we tested the model’s
ability to perform liver-specific functions (gluconeogenesis, triglyceride synthesis, amino acid degradation, and
ammonia and ethanol detoxification) as previously reported16 (see Data S3 (Table S4) for simulation results). The
iRatLiver model is provided in Data S1; an SBML version of the model is provided in Data S2.
There are several differences between human and rat metabolism38–40, most notably the existence of several
enzymes that are functional in rats but are present only as pseudogenes in humans (Table 1). We compared the
enzymes in rat and human and identified these unique enzymes that are functional in rats (see Methods section).
The human L-threonine 3-dehydrogenase gene is an expressed pseudogene41–44; whereas it is functional in rats,
suggesting that these differences should be taken into consideration for pharmacokinetic studies. Humans and rat
also differ in their ability to metabolize uric acid; rats have a functional uric acid oxidase, whereas humans have
a loss of uricase activity45.
We compared the iRatLiver model to an existing tissue-specific model of the human liver, liverCADRE16,
observing differences in several subsystems: vitamin C metabolism, vitamin B2 metabolism, fatty acid oxidation, tryptophan metabolism, and the pentose phosphate pathway (Supplementary Fig. 1A). Recently, Papin and
colleagues reported iRno, a GEM of rat30 that was used for biomarker prediction. A model of global rat metabolism, iRno encompasses all reactions in the organism rather than tissue-specific content and thus contains more
reactions and metabolites than does iRatLiver. We compared our liver-specific model to the global iRno model
(Supplementary Fig. 1B), finding fewer dead-end metabolites (five and 679, respectively), a result not unexpected
due to the differing scope between the models (Supplementary Fig. 1), i.e. a global reconstruction vs. a reconstruction more tailored to a particular organ. There have been several subsequent iterations of iRno focusing on
various aspects of rat physiology46–48.

Scientific Reports |

(2019) 9:9807 | https://doi.org/10.1038/s41598-019-46245-1

2

www.nature.com/scientificreports/

www.nature.com/scientificreports

Figure 1. Overview of study design. (a) Graphical representation of the experimental groups of rats considered
for studying the effect of diet restriction. The rats were divided into five groups based on their diet and the
experimental measurements were done at days 4 and 14. (b) Graphical representation of various analyses
performed in the study from reconstructing the rat liver model to identifying active reactions in diet restricted
conditions.

Validating iRatLiver predictions in diet-restriction conditions. Our next goal was to explore the
utility of iRatLiver for phenotypic predictions under a controlled perturbation. Diet restriction in rats has been
extensively studied in relation to a variety of medical applications, including obesity34, lifespan32,49, and drug
effects33,50. We therefore designed a study in which we altered the diet of groups of rats and studied the resulting
change in liver function through measuring gene expression (Fig. 1). A total of 50 male Sprague Dawley rats were
divided into five groups and given different diets; liver samples were taken at days 4 and 14 for five rats in each
group for transcriptomics analysis (see Methods for full details). From the gene expression data, we identified
differentially expressed genes (DEGs) (Data S3 (Table S2)) and corresponding biological processes that were
enriched for DEGs under diet-restriction conditions (Data S3 (Table S3)).
We then filtered the gene expression data to the set of metabolic genes to examine the effects of diet restriction
on liver metabolism. We performed principal component analysis (PCA) on the normalized expression values
of the metabolic genes, observing distinct clusters for the different experimental groups (Fig. 2). The control
samples (with or without overnight fasting) formed a separate cluster from the diet-restricted samples, corroborating previous results that suggested the expression of metabolic genes varies under varying dietary conditions51.
Further, the diet-restricted samples for days 4 and 14 clustered separately, indicating that the expression profile
was also influenced by the duration of the diet restriction. We observed high variance in the group 5 rats (60%
diet restriction), suggesting that there was a less uniform adaptive response. Ultimately, these results indicated
that the underlying expression profile of the liver varied as a function of time.
Analysis of the raw transcriptomics data provided a snapshot of biological processes that might be regulated
in various conditions, but our goal herein was to obtain a holistic view of how the metabolic network changed
as a result of diet restriction. Thus, we integrated the transcriptomics data into the iRatLiver model using previously published methods (GIMME12 and E-flux52); the two algorithms take different approaches to integrating
the expression data with the GEM, resulting in models with differing structure (see Methods). The resulting
condition-specific models (i.e., a model for each group of rats in the experimental design) allowed for the exploration of how metabolic fluxes and pathway usage were altered under nutrient deprivation.
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Figure 2. Principal component analysis (PCA) of metabolic genes present in transcriptome data. Colors
correspond to experimental groups; shapes represent time points (days 4 and 14).

We computed the flux state of the full metabolic network for all condition-specific models to identify reactions
that carried flux in all conditions. We selected the set of reactions from GIMME and E-flux that had non-zero
fluxes across a majority of conditions; this approach yielded a set of 1049 and 604 reactions that carried flux in
GIMME and E-flux, respectively. The intersection of those reactions resulted in a set of 338 high-confidence
reactions that were used in subsequent analysis (list of reactions provided in Data S3 (Table S5)). To obtain insight
into pathway regulation under the experimental conditions, we simulated the models (optimizing for growth
rate) and computed the flux state. These flux values were scaled using projective decomposition53, a normalization method that is part of Scale-Invariant Geometric Data Analysis (SIGDA)54, showing that various metabolic
subsystems cluster together (Fig. 3). We observed trends in the usage of several pathways in the group 5 rats (60%
less food) that were in the opposite direction when comparing the day 4 and 14 timepoints. This observation can
be explained by the fact that, during initial diet restriction, the liver is able to produce glucose from the catabolism of glycogen; under long-term diet restriction (during which glycogen stores have been depleted) glucose is
synthesized via gluconeogenesis from substrates such as lactate, pyruvate, glycerol, and amino acids generated in
the liver or originating from extrahepatic tissues55.

Understanding changes in pathway usage under diet-restricted conditions. While previous stud-

ies have explored the regulation of glycolysis, gluconeogenesis, TCA cycle and pentose phosphate metabolism55,56,
the iRatLiver model provides the opportunity to explore these questions in the context of the metabolic network.
To this end, we performed pathway-based enrichment analysis (Data S3 (Table S6)) on the genes present in
altered iRatLiver model subsystems. We found that glycolysis/gluconeogenesis, the pentose phosphate pathway
(PPP), fatty acid degradation, purine metabolism, and propanoate metabolism were significantly affected by diet
restriction. It has been previously reported that the activity of metabolic enzymes in PPP was reduced under
starvation conditions but restored through re-feeding with a high-carbohydrate diet33.
Upon deeper analysis of these subsystems, we observed that the distribution of reaction fluxes varied between
conditions (Fig. 4). Several reactions relevant to starvation conditions55, such as L-lactate dehydrogenase
(LDH_L) malate dehydrogenase (MDH), succinate dehydrogenase (SUCD1m), and phosphoribosylpyrophosphate synthetase (PRPPS), showed variations in fluxes across conditions55. Under starvation conditions, iRatLiver
correctly predicts the synthesis of glucose through gluconeogenesis, the conversion of lactate to pyruvate (by
LDH_L) to oxaloacetate in the mitochondria. The accumulation of TCA cycle intermediates in hepatocytes due
to gene deletion is responsible for hepatic steatosis in dietary restricted state55,56. In addition to these behaviors,
the iRatLiver model also predicted alterations in phosphoribosylpyrophosphate synthetase (PRPPS) under fasting
conditions.
We also examined the regulation of hormones, one of the main functions of the liver, and the subsequent
effect on various physiological functions in the system during diet restriction. Several genes in steroid metabolism were altered based on our metabolic analysis, namely hydroxysteroid 11-beta dehydrogenase 1 (Hsd11b1),
hydroxysteroid (17-beta) dehydrogenase (Hsd17b1, Hsd17b2, Hsd17b7, Hsd17b8), and aldo-keto reductase family 1 (Akr1c19). These genes are involved in various biological processes such as glucocorticoid biosynthesis,
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Figure 3. Comparison of flux states across experimental conditions. The clustergram on the left represents the
extent of alteration in the subsystems for observed conditions. Rows represent various subsystems in the model
and columns represent the experimental conditions. The values for each subsystem are normalized by projective
decomposition.

cholesterol biosynthetic process, fatty acid biosynthesis process, oxidation-reduction process as well as response
to nutrient levels. This observation suggests that hormone regulation is another important physiological change
that occurs during diet restriction.

Identifying key genes from network analysis. Finally, we attempted to understand transcriptional and
metabolic variations due to diet restriction using a network-based approach. We hypothesized that the metabolic
genes identified through integration of the gene expression data with the iRatLiver model were highly connected
nodes that orchestrated global metabolic functionality under changing environmental conditions.
To test this hypothesis, we constructed a protein expression network in which genes are nodes and interactions are edges (Fig. 5A; see Methods); the interaction between nodes may be a physical binding or function
association determined by putative or experimental evidence57. We identified the most highly connected nodes
(“hub” nodes) to be pyruvate kinase (Pkm, Pklr), hydroxyacyl-CoA dehydrogenase (Hadha), transketolase and
transketolase-like protein (Tkt, Tktl1, Tktl2), phosphoglucomutase (Pgm1), triosephosphate isomerase (Tpi1),
and enolase (Eno3). We calculated the node degree distribution (the number of connections the node has to
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Figure 4. Pathway-based analysis for glycolysis, TCA cycle and pentose phosphate pathway. The bar graphs
represent the distribution of fluxes in each condition shown with respect to control overnight fasting samples.
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other nodes in the network) and edge betweenness (the number of shortest paths that go through an edge in the
network) for the network. The edge betweenness for glycerol kinase (Gk) and glyceraldehyde-3-phosphate dehydrogenase (Gapdh) was highest, indicating that many paths in the network traverse by this edge.
Interaction networks provide interesting insights into how genes related to diverse functions work in concert
to achieve broader systems-level functions58. We next explored how the hub nodes in our network are connected.
We observed similar trends in the expression of Hadha, Tpi, Gk, and Gapdh for in the day 4 and 14 diet-restricted
conditions. The trend varies for Tkt and Pgm1, indicating that these genes are differently regulated for under
different diet conditions. The expression levels of Tkt in our study are lower when compared to control samples.
Pgm1 is expressed at higher levels in the nutrient restriction conditions than control overnight fasting, except for
the 60% restricted food group at 14 days (Fig. 5B,C).

Discussion

The liver plays an important role in regulating metabolic homeostasis by catabolizing, storing, and altering nutrients, as well as detoxifying toxic substances present in the body. Targeted perturbation experiments in model
organisms allows for a systems-level characterization of the complex systems underlying liver metabolism. In
particular, rats are frequently used in pharmacological and metabolic studies due to physiological similarities
with humans. Here, we described a tissue-specific metabolic network model of the rat liver (iRatLiver) and used it
to study diet restriction in rats. We used the iRatLiver model to compute changes in the network-level metabolic
flux state of the system due to alterations in the nutritional status of 50 Sprague Dawley rats. We have provided
evidence that this in silico model is able to provide deeper insight into the metabolic alterations in rat due to diet
restriction. The results presented here have three primary implications.
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Figure 5. Protein expression network. (A) Protein interaction network representing shortlisted metabolic genes
from analysis. The genes (nodes) are colored based on the subsystem they belong to and node size denotes the
degree of connectivity of that node in the network. Highly connected nodes are bigger in size. The thickness of
edge is decided based upon its edge betweenness in the network. (B) Box plots of hub nodes gene expression at
Day 4. (C) Box plots of hub nodes gene expression at Day 14. Hub nodes were identified from network analysis.
Box colors indicate experimental conditions as shown in the legend.

First, upon diet restriction, the liver maintains homeostasis through regulation of metabolic activity across the
metabolic network. We observed that several key pathways – central carbon metabolism, fatty acid degradation,
purine metabolism, and propanoate metabolism – are responsible for the regulation of systems-level function
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under the diet restriction. Hepatocytes can use glucose and/or fatty acids as metabolic fuels, and selection of these
depends on hormonal regulation and nutrient levels. In fasting or nutrient starvation conditions, hepatocytes
predominantly depend on oxidation of fatty acids for energy supply55, an observation supported by our results
herein.
Second, the liver’s response varied with respect to short- and long-term diet restriction. The survival of rats
subjected to severely restricted diet indicates that the organism is able to alter its metabolism to maintain required
energy levels. Through integration of gene expression data with the iRatLiver model, we were able to identify the
genes and pathways responsible for the metabolic shifts that allowed the organisms to adapt to changing environmental conditions. We investigated reactions involved in carbohydrate metabolism (glycolysis/gluconeogenesis, TCA cycle, and PPP) and observed changes in the flux through phosphoribosylpyrophosphate synthetase
(PRPPS) in fasting conditions. PRPPS (Prps1, Prps1l1, Prps2) was previously reported to be affected by amino
acid depletion55,59, while mutations in Prps1 have been associated with hyperuricemia, hyperuricosuria, hypotonia, and ataxia and gain-of-function mutation results in PRS-1 superactivity60. Our investigation of differential
pathway usage under diet restriction therefore warrants further study to better characterize genetic factors that
influence the varied metabolic shifts observed here in short- and long-term diet restriction.
Third, network models have the potential to provide important insights into complex liver functions. The
construction of an interaction network allowed for the identification of key genes such as Pklr, Hadha, Tkt, Pgm1,
Tpi, Gk, and Gapdh involved in metabolic regulation during diet restriction. We observed that the expression
levels of Tkt were lower in diet restriction than in control samples. Transketolase (Tkt) is a key enzyme in pentose phosphate pathway and governs carbon flow. Akt is known to regulate Tkt activity, and it has been reported
that caloric restriction causes downregulation of the PI3K/Akt/mTOR pathway, ultimately affecting amino acid,
carbohydrate and purine metabolism61. Thus, we conclude that these pathways are affected under the conditions
studied here. Similarly, Pgm1 (Phosphoglucomutase) –involved in the interconversion of glucose-1-phosphate
and glucose-6-phosphate – has been connected to the regulation of glycogen content during nutritional stress in
the system62. In humans, Pgm1 plays a role in balancing cellular demand during nutrient depletion, thus helping
cell proliferation. Both Pgm1 and Tkt (identified here as hub nodes) have been implicated in cancer cell proliferation and have been studied as possible therapeutic targets61,62. Thus, it is possible that a network approach such
as the one presented here could be used in pharmaceutical studies for the identification of potential drug targets.
In this study, we used a systems approach to interrogate energy metabolism in the rat liver in a metabolic
network model context. Through the integration of transcriptomics data, we generated condition-specific models
that were used to compute pathway usage under different diet-restricted conditions. Our results suggest that the
construction of a detailed transcriptional regulatory network of the rat liver would lead to further important
insights into the effects of diet restriction, such as genes that are switched on or off during those stress conditions.
We anticipate that the iRatLiver model presented here, which we are making freely available to the scientific community, will also prove useful to others in studying important physiological and biomedical questions related to
obesity, aging, and pharmacology.

Methods

Reconstruction of an in silico metabolic model of rat liver. We used a previously published tissue-specific GEM of the human liver (liverCADRE16) for the construction of iRatLiver model. The liverCADRE model
displayed improved metabolic functionality and was useful in predicting biological outcomes. The liverCADRE
model consisted of 1763 reactions, 1402 metabolites, 994 unique genes and 80 subsystems16. Following the established protocol for reconstructing metabolic networks35, we identified homologous genes between human and rat
using Ensembl (GRCh37)63 and Homologene64 and replaced these human genes with the corresponding Rattus
norvegicus genes.
We incorporated information regarding known metabolic differences between rat and human (unique proteins in rat liver metabolism added to the iRatLiver model are summarized in Table 1)38–40. We performed protein
BLAST65 using an e-value cut-off of 1e-30 to identify matching proteins. Next, we compared metabolic pathways
in human and rat using EC2KEGG tool66. The list of unique proteins in rat along with the biological functions are
given in Table 1. We used KEGG67 and BioCyc68 to obtain information of metabolic reactions catalyzed by these
enzymes which were added to the iRatLiver model. We identified dead-end metabolites and blocked reactions in
the draft reconstruction. We used reaction file containing information from Recon 215, KEGG67 and BioCyc68 to
fill gaps in the model.
The resulting draft reconstruction consisted of 1843 reactions, 1477 metabolites, and 988 unique genes. We
then added reactions belonging to cholesterol metabolism, tryptophan metabolism, glycolysis, tyrosine metabolism and others using information from the human Recon 2 model15. We used the objective function from mouse
metabolic model iMM141569 with no modifications. The final iRatLiver model consisted of 1882 reactions, 1448
metabolites, 994 unique metabolic genes, 7 compartments, and 82 subsystems. We compared reactions and subsystems present in the human liver model (liverCADRE)16 and iRatLiver model and found differences in vitamin
B2, vitamin C, squalene and cholesterol synthesis, fatty acid oxidation, tryptophan as well as pentose phosphate
pathway.
iRatLiver model validation. We performed two primary sets of validation for iRatLiver. First, we compared the predicted doubling time of 16.3 hours with literature values, finding that it was consistent with the
reported doubling time of 16.9 hours in rat hepatocyte cell culture37. Second, we performed a previously used
array of tests to ensure the model could compute basic functionality of the liver16. Specifically, we tested the model’s ability to perform gluconeogenesis, triglyceride synthesis, amino acid degradation, and ammonia and ethanol
detoxification (see Data S3 (Table S4) for simulation results). We deposited iRatLiver in BioModels70 under the
identifier MODEL1811090001. The iRatLiver model is available as SBML format (Data S2).
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Experimental design for diet restriction study in rat. We studied the effects of varying levels of nutri-

ent deprivation on male Sprague Dawley rats, approximately 8–10 weeks of age, that were subjected to varying
levels of dietary restriction (Fig. 2 and Data 3 (Table S1)). Rats were housed in groups or stable pair of compatible
individuals at an AAALAC, International accredited facility and were cared for in accordance with the Guide
for the Care and Use of Laboratory Animals, 7th Edition71. All research protocols were reviewed and approved by
the Amgen Institutional Animal Care and Use Committee. Lighting in animal holding rooms was maintained
on 12:12 hr light:dark cycle, and the ambient temperature and humidity range was at 68 to 79 F and 30 to 70%,
respectively. Powdered feed (Harlan Tekland rodent diet 8640) was provided either ad libitum (groups 1 and 2),
reduced by 15% (group 3), reduced by 30% (group 4), or reduced by 60% (group 5). Reduction in food was calculated based on the average food consumption recorded for group 1 and 2 based on the previous 3 days. There
were 10 rats per group; five rats per group were subjected to 4 days of dietary restriction (necropsy on day 5) and
the remaining 5 per group were subjected to 14 days (euthanized on day 15). Groups 2–5 were fasted 8–12 hours
overnight prior to necropsy. Standard clinical and anatomic pathology endpoints were collected and examined
(not included in this study).

Transcriptome analysis. RNA extraction from rat hepatocytes was carried out using Qiagen (Valencia, CA)

RNeasy Mini kit and qiazol according to the manufacturer’s instructions to homogenize the tissues and chloroform for phase separation. Amplification was performed with Oligo dT primed RT using SSII, 2nd strand cDNA
synthesis, cleanup via Qiagen MinElute. Synthesis of biotinylated cRNA using the Enzo (Farmingdale, NY) amp
kit, cleanup of cRNA via Qiagen RNeasy Mini kit. Biotin-labeled aRNA products were hybridized to Affymetrix
(Santa Clara, CA) GeneChip Rat Genome 230 2.0 Arrays per manufacturer instructions provided on the product insert. Scans were carried out as per manufacturer instructions provided on the product insert. The scan files
were processed using Expression Console (Affymetrix) for quality control and subsequent results were used in
microarray data analysis.
All statistical analyses were executed using the R statistical computing platform (version 3.0.1). Expression
data were normalized using the Robust Multi-Array Average method implemented in the Bioconductor package
affy (version 1.38.1). The expression data was submitted in Gene Expression Omnibus (GEO)72 and the accession number for the data is GSE98621. A single Empirical Bayes model included in the Bioconductor package
EBarrays (version 2.2.0) package, Lognormal-Normal-Modified-Variance (LNN-MV), was used to calculate differentially expressed genes. These analyses were conducted separately for each treatment group. The function
crit.fun, setting FDR = 0.1, was used to calculate the minimum posterior probability required to deem a sequence
representing a gene significant in each treatment group.
Normalization and fold change analysis was performed as mentioned above. The fold change values were
calculated by considering the group of ad libitum, overnight fasting samples (Group 2) as control. The number of
DEGs in each condition are represented in Data S3 (Table S2). The number of DEGs are higher for Day 14 conditions as compared to the others, indicating that larger number of genes are altered during high stress conditions.
We identified sets of genes that are commonly up or down-regulated in various experimental groups. Enrichment
analysis of these genes gave information of the pathways were significantly enriched in these conditions. We used
the enrichment analysis performed by STRING v10.557 (see Data S3 (Table S3)).

®

Integration of transcriptomics data with iRatLiver.

To identify the metabolic changes taking place in
the liver, we integrated transcriptomic data with the iRatLiver model. Among available methods for integrating
omics data with metabolic model73, we implemented two different algorithms: Gene Inactivity Moderated by
Metabolism and Expression (GIMME)12 and E-Flux52. The two algorithms make differing assumptions for the
integration of transcriptomics data, resulting in differing outputs and interpretations of subsequently computed
physiological states.
The combination of these methods is helpful in identifying set of active reactions in condition of interest and
capturing extent of flux changes and reshaping the flux cone considering the measurements of gene expression.
Upon implementation of the algorithms, we computed the flux state (optimizing for growth rate) of each model
separately; the reactions with zero flux were identified (reactions with a flux less than 1E-06 were denoted as
carrying no flux). Reactions having non-zero fluxes were selected from the total set of reactions in the model.
Only those reactions having measurable fluxes from both methods were considered active and subsequently
used for analyzing reactions and determining which subsystems were perturbed under diet-restricted conditions. We considered absolute values of reaction fluxes and grouped the reactions based on their corresponding
subsystems. For each subsystem, we calculated average values of reaction fluxes. Considering group 2 (control,
overnight fasting) as control, we subtracted the average values calculated for each subsystem for diet-restricted
conditions. Then we carried out an unbiased approach to identify subsystem differences between diet-restricted
conditions. We used projective decomposition54 to normalize the average flux values and represented the values
in clustergram in Fig. 3. The normalized flux values ranged from −3 to 2 for different subsystems. We also carried
out flux variability analysis (FVA)74 and determined the robustness of metabolic model. The information related
to altered subsystems can be extrapolated to further identify possible rewiring in the system leading to adaptation
during diet-restricted state. The COBRA toolbox75,76 was implemented in MATLAB 2014a and academic licenses
of Gurobi Optimizer v7.5 and IBM CPLEX v12.7.1 were used to solve LP and MILP problems in this study.

Statistical analysis. Fisher’s exact test followed by a correction of the p-values for multiple testing using
Benjamini-Hochberg procedure was used for pathway-based enrichment of genes identified from metabolic analysis77. A P-value cutoff of 0.05 was considered statistically significant in all analyses.
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Network analysis and visualization.

The genes belonging to altered subsystems were used for network
analysis. STRING v10.557 was used for extracting confident interactions (STRING combined score >0.7) between
these genes/proteins of the specific organism. The genes are represented as nodes and the interaction between
nodes is called an edge. The interactions were visualized using Cytoscape78. We used the NetworkAnalyzer application in Cytoscape to calculate node degree distribution and edge betweenness. Nodes with highest connections
in the network are defined as ‘hub’ nodes. The number of shortest paths that go through an edge in the network
determines the edge betweenness.
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